Table 2.
Known siNET cell lines, their origin, immunohistochemical profile, growth profile, and original publication.
| Cell line (original publication) | Origin | Immunohistochemical profile | Growth profile | References |
|---|---|---|---|---|
| P-STS | G3 tumor of the terminal ileum | Pan-CK, serotonin, CD56, Syp, HISL19, NSE | Doubling time: 4 days–1 week, grows in mildly adherent culture with some non-adherent aggregates | Pfragner et al. (2009), Hofving et al. (2018) |
| GOT-1 | G1 carcinoid tumor liver metastasis | CgA, 5-HT, VMAT1, serotonin, NCAM | Doubling time: 18 days | Kölby et al. (2001), Hofving et al. (2018) |
| CNDT2.5 | G1 liver metastasis from an ileal carcinoid | Syp, NSE, produced serotonin, SSTR1-5 | Limited published data | Van Buren et al. (2007), Barazeghi et al. (2021) |
| HC45 | G1 liver metastasis from an ileal carcinoid | CgA, CgB, SSTR2, SSTR5, Syp, VMAT 1, vitamin D3 receptor | Limited published data | Stilling et al. (2007) |
| SS-C | Jejunal somatostatinoma | SSTR2, NSE, CgA, Syp | Doubling time: 3–6 days | Galli et al. (2006) |
| STC-1 (mouse) | Tumor from the duodenum of a RIP1Tag2/RIP2PyST1 mouse | Secretin, gastrin, somatostanin, CgA | Doubling time: 54 h | Rindi et al. (1990) |
This work is licensed under a